CD8A and neoplasm: In this study, we noticed that TP53 mutant EC showed abundant infiltration of CD8+ PD-1+ T cells in the tumor parenchyma and a high proportion of CD8+ T cells with PD-1 expression in the tumor mesenchyme, indicating unfavorable clinical outcomes of TP53 mutant EC.